Asia’s No. 1 by sales in the gelatin and collagen industry
First written in FY2026-H1. 4 of 5 entries say "Restated". Latest entry: 2026-08-07.
The whole theme swung hardest in 2025: 2 of 9 companies on the "Worse" side.
21 other companies' latest entry also says "Restated".
- 2026-08-07RestatedEarnings
「We are working to further accelerate growth and enhance corporate value, with the aim of becoming No. 1 in Asia by sales in the gelatin and collagen industry.」
The company continues to state its goal of becoming No. 1 in Asia by sales in the gelatin and collagen industry. - FY2026RestatedAnnual report
「To achieve the “No. 1 in Asia” position set out in the vision above and dramatically accelerate our growth, the Group has formulated new long-term management targets with the fiscal year ending March 2033 as the target period.」
The Company has continued to link its long-term vision of becoming “Asia's No. 1 by sales in the gelatin and collagen industry” to its long-term management targets for the fiscal year ending March 2033. - FY2026-H1First statedAnnual report
「With “Lead in Asia. Challenge the World.” as our vision, we will pursue the goal of becoming Asia's No. 1 by sales in the gelatin and collagen industry, while working to further accelerate our growth and enhance corporate value.」
The long-term management vision formulated in November 2025 explicitly stated for the first time the goal of becoming Asia's No. 1 by sales in the gelatin and collagen industry.